The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl)propylthiosulfonate of sodium

  title={The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl)propylthiosulfonate of sodium},
  author={Alexandra B Shintyapina and V. A. Vavilin and O. G. Safronova and Vyacheslav V. Lyakhovich},
  journal={PLoS ONE},
Tert-butylhydroquinone (tBHQ) is a highly effective phenolic antioxidant used in edible oils and fats in foods as well as in medicines and cosmetics. TBHQ has been shown to have both chemoprotective and carcinogenic effects. Furthermore, it has potential anti-inflammatory, antiatherogenic, and neuroprotective activities. TBHQ induces phase II detoxification enzymes via the Keap1/Nrf2/ARE mechanism, which contributes to its chemopreventive functions. Nonetheless, there is growing evidence that… 

Figures and Tables from this paper

Tertiary Butylhydroquinone Ameliorates Insulin Resistance and Liver Steatosis in Type 2 Diabetes Mellitus
T tertiary butylhydroquinone alleviated IR and liver steatosis in T2DM mice and the mechanism may relate to AMPKα2/PI3K/AKT pathway.
Changes in the spectrum of proteins and phospholipids in tissues of rats exposed to thiosulfonates
The results have shown that short-term administration of thiosulfonates in a dose of 300 mg/kg of body weight did not cause significant changes in the content of total protein and its fractions in liver tissue, whereas the effect of allyl and ethyl esters of Thiosulfoacid was accompanied by an increase in the totalprotein and albumin in the blood plasma.
Evaluation of seeds ethanolic extracts of Triplaris gardneriana Wedd. using in vitro and in vivo toxicological methods
The results showed that the extract exhibits approximately 60% of hemolytic activity at the highest tested concentration and toxicity against nauplii of Artemia sp.
Sexual Dimorphism in Drug Metabolism and Pharmacokinetics.
Sex and gender-based differences in the metabolism of drugs exist at various levels and it may be due to the genomic and non-genomic action of sex hormones.
Tert-butylhydroquinone attenuates osteoarthritis by protecting chondrocytes and inhibiting macrophage polarization.
Tert-butylhydroquinone significantly attenuated cartilage destruction in DMM-induced mice in vivo and might be a potential therapeutic strategy for protecting against OA development.
Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway
Tertiary butylhydroquinone could alleviate liver steatosis and increase cell survival, and the mechanism is due in part to β-arrestin-2 activation.


In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice
This is the first study to demonstrate the in vivo pharmacokinetics, activation of signaling kinases and induction of phase II/III drug metabolizing enzymes/transporter gene expression by BHA in the mice, and thein vivo activation of MAPK signaling proteins.
Findings indicate that CYP1A1 may be induced by the antioxidant tBHQ via an AhR-dependent mechanism.
Regulation of Human CYP2C9 Expression by Electrophilic Stress Involves Activator Protein 1 Activation and DNA Looping
It is shown that extracellular signal-regulated kinase and Jun N-terminal kinase are essential for tBHQ-induced expression of CYP2C9 and CYP 2C19 in human hepatocytes, and oxidative stress generated by exposure to electrophilic xenobiotics and metabolites induces the expression.
Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols.
The linear correlations demonstrate the possibility to predict the enhanced gene expression of enzymatic defenses by diphenols from quantum mechanical calculations of the ability of diphenol inducers to release electrons and of the electron affinity of their corresponding quinones.
Pharmacogenomics of Phenolic Antioxidant Butylated Hydroxyanisole (BHA) in the Small Intestine and Liver of Nrf2 Knockout and C57BL/6J Mice
The identification of Bha-regulated and Nrf2-dependent genes not only provides potential novel insights into the gestalt biological effects of BHA on the pharmacogenomics and spatial regulation of global gene expression profiles in cancer chemoprevention, but also points to the pivotal role of NRF2 in these biological processes.
Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice.
A potential link between cancer chemopreventive properties of soy derived phytochemicals, the transcription factor Nrf2 and prevention of prostate cancer is provided.
Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway.
Comparative effects of oltipraz and 3-methylcholanthrene on transfected cytochrome P4501A1 reporters support the general but relatively weak XRE-stimulating activity of ogtipraz, and raises questions about the contribution of AHR and other secondary induction pathways in the mechanism of oLTipraz.
This is the first demonstration that the phenolic antioxidant, tBHQ, can directly induce Cyp1a1 gene expression in an AHR-dependent manner and may represent a novel mechanism by which tB HQ promotes carcinogenicity.
Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen.
It is indicated that Nrf2 and the androgen receptor directly bind to and activate the mouse GST-P1 gene, which is regulated by androgen.
Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites.
A review provides an account of recent mechanisms proposed for both chemoprotective and carcinogenic effect of tBHQ.